Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic Insights into the Binding of Class IIa HDAC Inhibitors toward Spinocerebellar Ataxia Type-2: A 3D-QSAR and Pharmacophore Modeling Approach
Siddharth Sinha, Sukriti Goyal, Pallavi Somvanshi, et al.
Frontiers in Neuroscience (2017) Vol. 10
Open Access | Times Cited: 15

Showing 15 citing articles:

Recent Developments and Applications of the MMPBSA Method
Changhao Wang, D’Artagnan Greene, Li Xiao, et al.
Frontiers in Molecular Biosciences (2018) Vol. 4
Open Access | Times Cited: 536
Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2
Polina A. Egorova, Ilya Bezprozvanny
Neurotherapeutics (2019) Vol. 16, Iss. 4, pp. 1050-1073
Open Access | Times Cited: 45
Quantitative structure–activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries
Hai Pham‐The, Gerardo M. Casañola‐Martín, Karel Diéguez‐Santana, et al.
SAR and QSAR in environmental research (2017) Vol. 28, Iss. 3, pp. 199-220
Open Access | Times Cited: 37
In Silico Approaches for Investigating the Binding Propensity of Apigenin and Luteolin Against Class I HDAC Isoforms
Shabir Ahmad Ganai, Zeenat Farooq, Shahid Banday, et al.
Future Medicinal Chemistry (2018) Vol. 10, Iss. 16, pp. 1925-1945
Closed Access | Times Cited: 33
Combinatorial In Silico Strategy towards Identifying Potential Hotspots during Inhibition of Structurally Identical HDAC1 and HDAC2 Enzymes for Effective Chemotherapy against Neurological Disorders
Shabir Ahmad Ganai, Ehsaan Abdullah, Romana Rashid, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 32
Topological and system-level protein interaction network (PIN) analyses to deduce molecular mechanism of curcumin
Anupam Dhasmana, Swati Uniyal, Anukriti Anukriti, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 25
Alterations in the conformation and function of human serum albumin induced by the binding of methyl hydrogen phthalate
Siyao Zhang, Bijia Zhou, Like Zhou, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2022) Vol. 278, pp. 121335-121335
Closed Access | Times Cited: 15
Current developments in extracellular-regulated protein kinase (ERK1/2) inhibitors
Yuzhen Niu, Hong‐Fang Ji
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1464-1473
Closed Access | Times Cited: 13
Conformal prediction of HDAC inhibitors
Ulf Norinder, J. Jesús Naveja, Edgar López‐López, et al.
SAR and QSAR in environmental research (2019) Vol. 30, Iss. 4, pp. 265-277
Closed Access | Times Cited: 20
Simulation Based Investigation of Deleterious nsSNPs in ATXN2 Gene and Its Structural Consequence Toward Spinocerebellar Ataxia
Siddharth Sinha, Sharad Verma, Aditi Singh, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 1, pp. 499-510
Closed Access | Times Cited: 21
The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools
Mohammed Hussen Bule, Nafiseh Jalalimanesh, Zahra Bayrami, et al.
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 5, pp. 954-967
Closed Access | Times Cited: 15
Recent Prospectives of Anticancer Histone Deacetylase Inhibitors
Shymaa A. Abbass, Heba Hassan, Mamdouh F. A. Mohamed, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2019)
Open Access | Times Cited: 13
Hyphenated 3D-QSAR statistical model-drug repurposing analysis for the identification of potent neuraminidase inhibitor
Rohini Karunakaran, V. Shanthi
Cell Biochemistry and Biophysics (2018) Vol. 76, Iss. 3, pp. 357-376
Open Access | Times Cited: 12
Structure-based virtual screening for novel potential selective inhibitors of class IIa histone deacetylases for cancer treatment
Ammar D. Elmezayen, Kemal Yelekçi
Computational Biology and Chemistry (2021) Vol. 92, pp. 107491-107491
Closed Access | Times Cited: 8
E-pharmacophore hypothesis strategy to discover potent inhibitor for influenza treatment
Rohini Karunakaran, Roosha Roy, K. Ramanathan, et al.
Journal of Theoretical and Computational Chemistry (2019) Vol. 18, Iss. 04, pp. 1950021-1950021
Closed Access | Times Cited: 5
Page 1

Scroll to top